From May 31, 2023 to February 26, 2024, the company has repurchased 56,975,656 shares, representing 4.37% for $53.34 million. With this, the company has completed the repurchase of 56,975,656 shares, representing 4.37% for $53.34 million under the buyback announced on May 31, 2023.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.859 USD | -0.12% | -2.16% | +2.26% |
May. 02 | BioPharma Credit Enters $400 Million Loan Agreement with Novocure Luxembourg | MT |
May. 02 | BioPharma Credit agrees USD400 million loan for oncology firm Novacure | AN |
1st Jan change | Capi. | |
---|---|---|
+2.26% | 1.05B | |
+7.14% | 13.19B | |
+10.13% | 9.46B | |
+1.10% | 5.65B | |
+9.70% | 5.64B | |
+7.41% | 5.28B | |
+33.17% | 5.22B | |
+26.13% | 4.82B | |
+2.65% | 4.08B | |
+6.94% | 3.99B |
- Stock Market
- Equities
- BPCP Stock
- News BioPharma Credit PLC
- Tranche Update on BioPharma Credit PLC's Equity Buyback Plan announced on May 31, 2023.